Expected earnings - Pacific Biosciences of California Inc.
Source: US Earnings Reports
Pacific Biosciences of California Inc. (PACB) is expected to report $-0.18 for Q2 2025
Pacific Biosciences of California Inc.
NASDAQ: PACB
PACB Trading
4.72% G/L:
$1.33 Last:
3,202,013 Volume:
$1.30 Open:
PACB Latest News
March 05, 2026 08:30:00 am
PacBio Announces the Appointment of Chris Gibson to the Board of Directors
February 24, 2026 09:05:00 am
PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research
February 18, 2026 04:05:00 pm
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference
PACB Stock Data
$549,471,524
294,359,745
0.64%
78
N/A
Biotechnology & Life Sciences
Healthcare
US
Menlo Park
